.png){kind=icon}
.png){kind=icon}
Return
Rising Burden and Clinical Impact of Metabolic Syndrome in Inflammatory Bowel Disease: A Real-World Cohort Study
.png){kind=icon}
OA
AI
R
K
M
R
A
DOI：10.1002/ueg2.70255.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Metabolic syndrome (MetS) and its cardiometabolic complications are recognized in inflammatory bowel disease (IBD); however, longitudinal trends and their impact on outcomes remain incompletely defined. We aimed to evaluate temporal trends in cardiometabolic comorbidities and assess the impact of MetS on cardiometabolic, hepatic, renal, and IBD-related outcomes.
Keywords:
cardiometabolic comorbidities
Crohn's disease
inflammatory bowel disease
metabolic dysfunction–associated steatotic liver disease
metabolic syndrome
obesity
ulcerative colitis
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.7
Papers:
1.9K
Citations:
4.9K
Organization
Cited Papers